v3.23.2
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Equity [Abstract]    
SCHEDULE OF STOCK WARRANTS VALUATION ASSUMPTIONS

The fair value of stock warrants granted for the 6 months ended June 30, 2022 was calculated with the following assumptions:

 

   June 30, 2023   June 30, 2022 
Risk-free interest rate   3.97%   1.53%
Expected dividend yield   0%   0%
Volatility factor (monthly)   147.58%   169.27%
Expected life of warrant   5 years    5 years 

The fair value of stock warrants granted for the year ended December 31, 2021 was calculated with the following assumptions:

 

 

   2022    2021 
Risk-free interest rate   1.37 – 4.45%    0.16 - 1.00%
Expected dividend yield   0%    0%
Volatility factor (monthly)   155.52%    175.34%
Expected life of warrant   5 years     5 years 
SCHEDULE OF WARRANT ACTIVITY

The following table summarizes the Company’s common stock warrant activity for the 6 months ended June 30, 2023 and 2022:

 

    Number of Warrants*     Weighted Average Exercise Price     Weighted- Average Remaining Expected Term  
Outstanding as at January 1, 2022     272,000     $ 2.00       2.9  
Granted     264,030       0.26       5.0  
Exercised     —       —       —  
Forfeited/Canceled     —       —       —  
Outstanding as at June 30, 2022     536,030       1.14       3.7  
                         
Outstanding as at January 1, 2023     542,030     $ 0.42       4.1  
Granted     800,000       0.20       5.0  
Exercised     —       —       —  
Forfeited/Canceled     —       —       —  
Outstanding as at June 30, 2023     1,342,030     $ 0.29       4.4  

 

* The warrant agreements issued in 2019 for a total of 50,000 warrants include provisions for dilutive issuance and cash-less exercise. If exercised at December 31, 2022 the provisions would have resulted in an issuance of 1,130,114 shares at an average conversion price of $0.09, or 1,050,114 shares in a cash-less exercise. In order to mitigate the Company’s risk an administrative hold has been placed on one shareholder’s stock in the event of future exercise.

The following table summarizes the Company’s Common Stock warrant activity for the year ended December 31, 2022 and 2021:

 

  

Number of

Warrants *

  

Weighted Average

Exercise Price

  

Weighted Average

Remaining

Expected Term

 
Outstanding as at January 1, 2021   272,000   $2.00    3.9 
Granted   —    —    — 
Exercised   —    —    — 
Forfeited/Cancelled   —    —    — 
Outstanding as at December 31, 2021   272,000    2.00    3.7 
Granted   492,030    0.26    5.0 
Exercised   (200,000)   2.00    — 
Forfeited/Cancelled   (22,000)   2.00    — 
Outstanding as at December 31, 2022   542,030   $0.42    4.1 

 

* The warrant agreements issued in 2019 for a total of 50,000 warrants include provisions for dilutive issuance and cash-less exercise. If exercised at December 31, 2022 the provisions would have resulted in an issuance of 1,130,114 shares at an average conversion price of $0.09, or 1,050,114 shares in a cash-less exercise. In order to mitigate the Company’s risk an administrative hold has been placed on one Shareholder’s stock in the event of future exercise.
SCHEDULE OF WARRANT OUTSTANDING AND EXERCISABLE WARRANTS

The following table summarizes information about stock warrants that are vested or expected to vest at June 30, 2023:

 

    Warrants Outstanding           Exercisable Warrants     
Number of Warrants  

Weighted

Average

Exercise

Price

Per Share

   Weighted Average Remaining Contractual Life (Years)   Aggregate Intrinsic Value   Number of Warrants   Weighted Average Exercise Price Per Share   Weighted Average Remaining Contractual Life (Years)  

Aggregate Intrinsic

Value

 
 800,000   $0.20    4.9   $—    800,000   $0.20    4.9   $— 
 492,030    0.26    3.8    —    492,030    0.26    4.1    — 
 50,000    2.00    1.3    —    50,000    2.00    1.3    — 
 1,342,030   $0.29    4.4   $—    1,342,030   $0.29    4.4   $— 

The following table summarizes information about stock warrants that are vested or expected to vest at December 31, 2022 with a market price of $0.48 at December 31, 2022:

 

 

    Warrants Outstanding           Exercisable Warrants     
Number of Warrants  

Weighted

Average

Exercise

Price

Per Share

   Weighted Average Remaining Contractual Life (Years)   Aggregate Intrinsic Value   Number of Warrants   Weighted Average Exercise Price Per Share   Weighted Average Remaining Contractual Life (Years)  

Aggregate Intrinsic

 

Value

 
 492,030    0.26    4.3   $107,014    492,030    0.26    4.3   $107,014 
 50,000   $2.00    1.8   $—    50,000   $2.07    1.8   $— 
 542,030   $1.14    4.1   $107,014    542,030   $0.42    4.1   $107,014 
SCHEDULE OF NON-VESTED WARRANTS

The following table sets forth the status of the Company’s non-vested warrants as at June 30, 2023 and 2022:

 

    Number of Warrants    

Weighted-Average

Grant-Date Fair Value

 
Non-vested as at January 1, 2022     —       —  
Granted     264,030       0.25  
Forfeited     —       —  
Vested     —       —  
Non-vested as at June 30, 2022     —     $ —  
                 
Non-vested as at January 1, 2023     —     $ —  
Granted     800,000       0.20  
Forfeited     —       —  
Vested     —       —  
Non-vested as at June 30, 2023     —     $ —  

The following table sets forth the status of the Company’s non-vested warrants as at December 31, 2022, there were no warrants issued for the year ended at December 31, 2021.

 

 

   Number of Warrants   Weighted- Average Grant-Date Fair Value per share 
Non-vested as at December 31, 2021   —   $— 
Granted   492,030    0.26 
Forfeited/Cancelled   —    — 
Vested   492,030    0.26 
Non-vested as at December 31, 2022   —   $—